SCHEMBL2144202

SCHEMBL2144202

O=C(c1cc(Br)c2cccnc2c1O)N1Cc2ccccc2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.55
KDM4E B2RXH2 5/20 0.53
HTT P42858 3/20 0.53
TDP1 Q9NUW8 2/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
TP53 P04637 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
USP2 O75604 1/20 0.52
HSP90AB1 P08238 8/20 0.48
TRAP1 Q12931 3/20 0.48
HSP90B1 P14625 3/20 0.48
CTSB P07858 1/20 0.46
NPSR1 Q6W5P4 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2143724 0.80 ALDH1A1 (0.58) HSP90AA1KDM4EHTTALDH1A1HPGD
SCHEMBL2144196 0.79 KDM4E (0.54) HSP90AA1KDM4EHTTTDP1LMNA
SCHEMBL2143785 0.77 KDM4E (0.78) HSP90AA1KDM4EHTTTDP1LMNA
SCHEMBL4159437 0.75 PARP1 (0.54) HSP90AA1KDM4EHTTLMNAALDH1A1
SCHEMBL23015525 0.75 HSP90AB1 (0.64) HSP90AA1HSP90AB1TRAP1HSP90B1
SCHEMBL21902359 0.73 KDM4E (0.59) HSP90AA1KDM4EHTTTDP1LMNA
SCHEMBL2143763 0.72 PRMT5 (0.58) HSP90AA1KDM4EHTTTDP1LMNA
SCHEMBL384603 0.72 HSP90AA1 (1.00) HSP90AA1HSP90AB1TRAP1HSP90B1
Broxyquinoline SCHEMBL115293 0.70 KDM4E (1.00) HSP90AA1KDM4EHTTTDP1LMNA
Broxyquinoline SCHEMBL29607319 0.70 KDM4E (1.00) HSP90AA1KDM4EHTTTDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 EP claimed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 US claimed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 US claimed
EP-2345643-A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM S.A. (LU) 2011-07-20 EP claimed
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 EP disclosed
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 EP disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 US disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 US disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 US disclosed
EP-2519505-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF Polichem SA (LU) 2012-11-07 EP disclosed
EP-2345643-A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM S.A. (LU) 2011-07-20 EP disclosed
WO-2011080264-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM S.A. (LU) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF TUBA8, SUCLG1, TUBB8 HSP90AA1 1486/4885KDM4E 2814/4885HTT 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.